Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
1.105
+0.010 (0.91%)
Mar 25, 2026, 12:44 PM EDT - Market open

Health Catalyst Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-177.97-69.5-118.15-137.4-153.21
Depreciation & Amortization
50.541.4342.2248.337.53
Stock-Based Compensation
27.0140.1355.7672.165.15
Other Adjustments
116.313.160.76-4.3622.8
Change in Receivables
-1.814.28-13.660.790.1
Changes in Accounts Payable
-11.515.584.87-4.75.2
Changes in Unearned Revenue
0.61-7.01-1.49-67.64
Changes in Other Operating Activities
-2.4-3.51-3.39-4-8.33
Operating Cash Flow
0.7314.56-33.08-35.27-23.12
Operating Cash Flow Growth
-94.98%----
Capital Expenditures
-0.97-1.62-1.24-2.17-10.45
Sale of Property, Plant & Equipment
0.040.010.030.030.02
Purchases of Intangible Assets
-20.59-14.78-13.08-15.25-8.02
Purchases of Investments
-65.13-168.31-290.84-308.96-261.36
Proceeds from Sale of Investments
163.95242.07336.8315.17186.89
Payments for Business Acquisitions
-41.11-80.28-11.39-27.85-46.76
Investing Cash Flow
36.19-22.920.29-39.02-139.68
Long-Term Debt Issued
-152.28---
Long-Term Debt Repaid
-232.29-0.96---
Net Long-Term Debt Issued (Repaid)
-232.29151.32---
Issuance of Common Stock
1.512.584.547.12270.37
Repurchase of Common Stock
-5--1.81-8.39-
Net Common Stock Issued (Repurchased)
-3.492.582.73-1.27270.37
Other Financing Activities
--2.15--1.34-6.29
Financing Cash Flow
-235.78151.752.73-2.61264.08
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.03-0.030.02-0.01-0.01
Net Cash Flow
-198.83143.37-10.04-76.92101.27
Free Cash Flow
-0.2412.94-34.32-37.44-33.57
FCF Margin
-0.08%4.22%-11.60%-13.55%-13.88%
Free Cash Flow Per Share
-0.000.22-0.61-0.69-0.71
Levered Free Cash Flow
-374.04116.69-77.17-105.97-121.62
Unlevered Free Cash Flow
-123.98-34.6-85.53-112.8-118.25
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q